National Health Investors (NHI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Announced appointment of Robert W. Chapin, Jr. to the Board of Directors, expanding the board to eight members effective immediately.
Chapin brings over three decades of executive experience in private equity and real estate investment, particularly in senior housing and medical properties.
Chapin will serve on the special committee of disinterested directors to oversee potential lease negotiations and alternatives between the company and NHC.
Forward-looking statements highlight growth opportunities, capital market strategies, and risk factors affecting future performance.
Voting matters and shareholder proposals
Details regarding board nominees for the 2025 Annual Meeting will be included in the upcoming proxy statement.
Shareholders are urged to review all proxy materials and related filings before voting.
Board of directors and corporate governance
Board size increased to eight members with the addition of Chapin.
Chapin's appointment was recommended by the Nominating and Corporate Governance Committee.
Chapin will stand for election at the 2025 annual meeting.
No related party transactions or arrangements influenced Chapin's appointment.
Latest events from National Health Investors
- Normalized FFO per share rose 8.9% in Q4, with SHOP NOI up 125% and 2026 outlook strong.NHI
Q4 202527 Feb 2026 - Q2 FFO, FAD, and revenues rose, but net income fell; SHOP occupancy and guidance increased.NHI
Q2 20242 Feb 2026 - SHOP occupancy and NOI surged, but net income and FFO per share declined; liquidity remains strong.NHI
Q3 202416 Jan 2026 - Q4 and 2024 outperformed, with strong growth and 2025 guidance signaling further gains.NHI
Q4 20246 Jan 2026 - Proxy contest aims to overhaul board independence and governance, urging immediate declassification.NHI
Proxy Filing1 Dec 2025 - Strong financial results, board refreshment, and major governance reforms headline this year's proxy.NHI
Proxy Filing1 Dec 2025 - Board refreshment, strong financials, and governance reforms drive growth and shareholder value.NHI
Proxy Filing1 Dec 2025 - Board refreshment, strong returns, and governance enhancements drive long-term growth.NHI
Proxy Filing1 Dec 2025 - Proxy contest targets board independence, conflicts, and supports declassifying the board.NHI
Proxy Filing1 Dec 2025